H. Casey Logan plans to resign as chief business officer of TRACON Pharmaceuticals Inc., effective March 2, to pursue a new professional opportunity.
Logan's resignation is not a result of any disagreement with the company.
TRACON Pharmaceuticals chief business officer to resign
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
H. Casey Logan plans to resign as chief business officer of TRACON Pharmaceuticals Inc., effective March 2, to pursue a new professional opportunity.
Logan's resignation is not a result of any disagreement with the company.